Seegene Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.035x

Seegene Inc cash flow conversion efficiency. Based on the latest financial reports, Seegene Inc (096530) has a cash flow conversion efficiency ratio of 0.035x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩36.26 Billion ≈ $24.57 Million USD) by net assets (₩1.04 Trillion ≈ $704.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Seegene Inc (2012–2025)

Cash flow conversion efficiency of Seegene Inc from 2012 to 2025. This chart illustrates how Seegene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Seegene Inc for real-time trading data and today's change.

Seegene Inc Cash Flow Conversion Ratio Explained

Seegene Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Seegene Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Seegene Inc ranked by their cash flow conversion efficiency. Also see Seegene Inc (096530) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Zhejiang Great Shengda Packaging Co Ltd SHG:603687	0.033x
Zhejiang Yankon Group Co Ltd SHG:600261	0.022x
Hubei Heyuan Gas Co Ltd SHE:002971	0.062x
Cangzhou Mingzhu Plastic Co Ltd SHE:002108	-0.008x
Quanex Building Products NYSE:NX	0.026x
Latigo Biotherapeutics, Inc. Common Stock NASDAQ:LTGO	0.077x
CHERVON HOLDINGS LTD F:AZ9	N/A
Hangjin Technology Co Ltd SHE:000818	0.174x

Annual Cash Flow Conversion Efficiency for Seegene Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Seegene Inc from 2012 to 2025. Review cash generation quality of Seegene Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩1.02 Trillion ≈ $688.40 Million	₩149.33 Billion ≈ $101.20 Million	0.147x	+68.97%
2024-12-31	₩981.48 Billion ≈ $665.13 Million	₩85.39 Billion ≈ $57.87 Million	0.087x	-5.57%
2023-12-31	₩1.03 Trillion ≈ $698.29 Million	₩94.93 Billion ≈ $64.33 Million	0.092x	-66.85%
2022-12-31	₩1.15 Trillion ≈ $777.83 Million	₩319.01 Billion ≈ $216.19 Million	0.278x	-10.02%
2021-12-31	₩1.08 Trillion ≈ $732.85 Million	₩334.02 Billion ≈ $226.36 Million	0.309x	-47.98%
2020-12-31	₩645.32 Billion ≈ $437.32 Million	₩383.16 Billion ≈ $259.66 Million	0.594x	+233.73%
2019-12-31	₩152.55 Billion ≈ $103.38 Million	₩27.14 Billion ≈ $18.39 Million	0.178x	+62.59%
2018-12-31	₩128.03 Billion ≈ $86.76 Million	₩14.01 Billion ≈ $9.49 Million	0.109x	+35.27%
2017-12-31	₩125.04 Billion ≈ $84.74 Million	₩10.12 Billion ≈ $6.86 Million	0.081x	-30.63%
2016-12-31	₩141.97 Billion ≈ $96.21 Million	₩16.56 Billion ≈ $11.22 Million	0.117x	+612.54%
2015-12-31	₩135.09 Billion ≈ $91.55 Million	₩-3.07 Billion ≈ $-2.08 Million	-0.023x	-131.84%
2014-12-31	₩94.83 Billion ≈ $64.27 Million	₩6.78 Billion ≈ $4.59 Million	0.071x	+308.60%
2013-12-31	₩84.44 Billion ≈ $57.23 Million	₩-2.89 Billion ≈ $-1.96 Million	-0.034x	-139.12%
2012-12-31	₩41.94 Billion ≈ $28.42 Million	₩3.67 Billion ≈ $2.49 Million	0.088x	--

About Seegene Inc

KQ:096530 Korea Biotechnology

Market Cap

$966.49 Million

₩1.43 Trillion KRW

Market Cap Rank

#8716 Global

#223 in Korea

Share Price

₩31300.00

Change (1 day)

-3.84%

52-Week Range

₩21850.00 - ₩38900.00

All Time High

₩140042.88